Who We Are
Debbie, Quality Control
“By doing my job—and providing a patient with hope for more time to spend with his or her family—it makes it all worthwhile.”
Researchers all over the world have sought to harness the human immune system to fight cancer. Here at Dendreon, our decade-plus journey has involved more than a thousand courageous patients, more than a dozen clinical trials, and nearly one billion dollars of funding. And throughout this journey, our guiding principle has been simple: patients first.
Many of us have been affected by cancer, which is why we’re dedicated to revolutionizing the way this disease is treated. We promise to continue to build, continue to invest, and continue to do everything we can to develop more targeted therapies to help give cancer patients hope.